Skip to content

An observational study to determine thromboembolism prophylaxis in cancer patients

An observational study to determine Thromboembolism prophylaxis in oncology patients who are undergoing abdominal or pelvic surgery - RESPONSE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/05/003617
Enrollment
295
Registered
2013-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I824- Acute embolism and thrombosis of deep veins of lower extremity Health Condition 2: null- Thromboembolism prophylaxis in oncology patients who are undergoing abdominal or pelvic surgery

Interventions

None listed

Sponsors

SanofiSynthelabo India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or female patient >= 18 years of age 2. Patients hospitalized for surgery of abdominal or pelvic (such as colon, rectum, stomach, liver, pancreas, prostate, urinary bladder, uterus and ovarian) malignant tumor 3. Patients who have undergone surgery for this malignant tumor in the last 2 days 4. Signed Informed consent

Exclusion criteria

Exclusion criteria: 1.Patient with a life expectancy of less than 1 month 2.Patient currently participating in a clinical trial

Design outcomes

Secondary

MeasureTime frame
1. Proportion of patients who develop symptomatic DVT at the end of 30 days 2. To evaluate the profile of patients who are admitted (in terms of: Age, gender, type of malignant tumor, stage of malignancy, type of admitting hospital). The profile of the patients will be analyzed for thromboprophylaxis given or not and if the patient develops symptomatic DVT or not. 3. Reasons for not administering thromboprophylaxis Timepoint: 30 days

Primary

MeasureTime frame
Proportion of oncology patient undergoing surgery for the malignant abdominal or pelvic tumor who are given thromboprophylaixs Timepoint: not applicable

Countries

India

Contacts

Public ContactSalini James

Sanofi

deepa.chodankar@sanofi.com09096867313

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 23, 2026